BioSpace News Archive

Biotech Beach

Nexcella, Immix Biopharma Subsidiary, to Present at the Bank of America 2023 Healthcare Trailblazers Private Company Conference

Immix Biopharma, Inc. today announced that Nexcella NXC-201 clinical data will be presented by Ilya Rachman, MD, PhD, and Gabriel Morris at the Healthcare Trailblazers Private Company Conference Thursday, October 26, 2023.

September 7, 2023

·

5 min read

INmune Bio Inc. to Present at Baird Global Healthcare Conference and H.C Wainwright 25th Annual Global Investment Conference

INmune Bio (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness a patient’s immune system to fight disease, announced today that RJ Tesi, MD, Chief Executive Officer, and David Moss, Chief Financial Officer, will participate in two September 2023 conferences.

September 7, 2023

·

3 min read

Drug Development

Sorrento Therapeutics Announces Positive Phase 2a Clinical Trial Results for Resiniferatoxin (RTX) for the Treatment of Knee Pain in Moderate to Severe Osteoarthritis of the Knee (OAK) Patients

Sorrento Therapeutics, Inc. (OTC: SRNEQ, “Sorrento”) announced today positive Phase 2a top-line clinical trial results for the RTX program.

September 7, 2023

·

13 min read

Bio NC

Fennec Pharmaceuticals to Participate in Upcoming September 2023 Investor Conferences

Fennec Pharmaceuticals Inc., a commercial stage specialty pharmaceutical company, announced that the Company will be participating in upcoming conferences.

September 7, 2023

·

5 min read

SciSparc Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement

SciSparc Ltd. announced that it has received a notification letter from Nasdaq Stock Market LLC that the Company has been granted an additional 180-day compliance period, or until March 4, 2024 to regain compliance with Nasdaq’s minimum bid price rule.

September 7, 2023

·

3 min read

Pharm Country

West to Participate in Upcoming September 2023 Investor Conference

West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced that it will present at Bank of America Global Healthcare Conference in London, UK on Thursday, September 14, 2023 at 10:50 AM BST.

September 7, 2023

·

1 min read

Genetown

Scientists detail current evidence that Long COVID is caused by persistent SARS-CoV-2 viral reservoirs

PolyBio Research Foundation is excited to announce a new publication in the journal Nature Immunology.

September 7, 2023

·

2 min read

Biotech Bay

New one-year results for Kodiak’s tarcocimab tedromer in the pivotal BEACON trial reinforce durability signal and demonstrate matched efficacy and comparable safety and tolerability in retinal vein occlusion

Kodiak Sciences Inc. announced top-line, one-year results for its ABC Platform based investigational therapy tarcocimab tedromer 5 mg from the pivotal BEACON study in patients with macular edema due to retinal vein occlusion.

September 7, 2023

·

10 min read

Drug Development

Phanes Therapeutics Announces First Patient Dosed in Phase 1 Study of PT217 for Small Cell Lung Cancer and Other Neuroendocrine Cancers Expressing DLL3

Phanes Therapeutics, Inc. announced that the first patient has been dosed in the Phase 1 clinical study of PT217, a first-in-class native IgG-like bispecific antibody targeting DLL3 and CD47 for the treatment of small cell lung cancer and other neuroendocrine tumors.

September 7, 2023

·

2 min read

Genetown

Mariana Oncology Announces $175 Million Series B Financing

Mariana Oncology Inc., a biotechnology company pioneering a new era of radiopharmaceutical innovation to treat cancers with high unmet need, announced the closing of an oversubscribed $175 million Series B financing co-led by Deep Track Capital and Forbion.

September 7, 2023

·

3 min read